Thus there is a positive feed-back loop between cyclin-A/Cdk2 and Aurora-A pathways in the development of centrosome amplification in breast cancer cells which may be which may provide additional approaches to target drug resistant breast cancer patients [244]. This evidence concerns the gene CDK2 and breast carcinoma.